Preliminary results of a phase II study of neoadjuvant checkpoint blockade for surgically resectable undifferentiated pleomorphic sarcoma (UPS) and dedifferentiated liposarcoma (DDLPS).

Roland, CL; Keung, EZY; Lazar, AJ; Torres, KE; Wang, WL; Guadagnolo, A; Bishop, AJ; Lin, HY; Hunt, K; Feig, BW; Bird, JE; Lewis, VO; Tawbi, HAH; Ratan, R; Patel, S; Wargo, JA; Somaiah, N

JOURNAL OF CLINICAL ONCOLOGY, 2020; 38 (15):